Reimportation Advocates Have Support Of “Rogue” Pfizer Exec
The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec
The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec